关键词: 脑梗死; 脑缺血发作; 短暂性; 血小板聚集抑制剂; 二级预防

Abstract: In all patients with cerebrovascular disease, ischemic stroke accounts for about 80%. Moreover, ischemic stroke patients, many of whom accompanied by multiple risk factors suffer high risk of stroke recurrence. In the secondary prevention of non-cardiac ischemic stroke / transient ischemic attack (TIA), the effcacy of anti-platelet therapy has been verifed by a large number of clinical studies, and was recommended by national guidelines of many countries. According to recent guideline and classical clinical trials, we make a review about the model of antiplatelet therapy for ischemic stroke or TIA of non-cardiac origin.

Key words: Brain infarction; Ischemic attack; transient; Platelet aggregation inhibitors; Secondary prevention